Biogen introduces Spinal Muscular Atrophy (SMA) Policy and Access Tracker
Biogen has collaborated with SMA Europe to develop a tool called the Spinal Muscular Atrophy (SMA) Policy and Access Tracker, which offers an in-depth assessment of how 23 European countries are performing in terms of access to SMA treatment, care and supporting policies, identifies the major areas for improvement, and provides policy recommendations to tackle…
